This filing is a routine compensation adjustment with no material impact on operations or financials. Monitor for any future equity plan amendments or share issuances that may affect dilution.
Price Chart
Executive Summary
DNA X, Inc. filed an 8-K disclosing that its compensation committee approved a substitute cash grant to all board members, including CEO Mike Mulica, in lieu of restricted stock units (RSUs) due to insufficient shares available under the 2019 Equity Incentive Plan. The phantom RSUs are valued at $60,000 and will vest at the 2027 annual meeting or upon a change in control, with the cash payout equal to the fair market value at vesting. This is a routine compensatory arrangement with no material financial impact.
Key Facts
- On August 21, 2026, the compensation committee approved a Substitute Cash Grant to all board members, including CEO Mike Mulica.
- The grant replaces RSUs under the 2019 Equity Incentive Plan due to unavailability of shares.
- Phantom RSUs valued at $60,000 based on fair market value on August 21, 2026.
- Vesting occurs upon the earlier of the 2027 annual meeting or a change in control.
- The cash award equals the fair market value of the underlying common stock at vesting.
Financial Impact
Phantom RSUs valued at $60,000; cash payout contingent on future stock price at vesting.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040324 |
| Document: 0001493152-26-040324-index.html | 0001493152-26-040324 |
| Document: 0001493152-26-040324.txt | 0001493152-26-040324 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 8w ago | 8-K | $3.53 $4.57 | ▲ +29.50% | ▲ +29.19% | $2.96 (−16.03%) |
Aug 27, 2026 8w ago | 8-K | $3.27 $4.06 | ▲ +24.16% | ▲ +24.26% | $2.96 (−9.48%) |
Aug 19, 2026 9w ago | Press Release | $3.44 $2.96 | ▲ +13.95% | ▲ +13.95% | $2.96 (+13.95%) |
Jul 2, 2026 16w ago | 8-K | $3.75 $3.25 | ▲ +13.33% | ▲ +12.92% | $2.96 (+21.07%) |
Jun 12, 2026 19w ago | EFFECT | $4.74 $4.05 | ▲ +14.56% | ▲ +16.34% | $2.96 (+37.55%) |
Jun 4, 2026 20w ago | 8-K | $4.75 $4.21 | ▼ −11.37% | ▼ −13.23% | $2.96 (−37.68%) |
May 27, 2026 21w ago | 8-K | $4.24 $5.70 | ▼ −34.43% | ▼ −37.58% | $2.96 (+30.19%) |
Apr 30, 2026 25w ago | 8-K / 10-K/A | $4.89 $4.73 | ▲ +3.27% | ▲ +8.56% | $2.96 (+39.47%) |
Apr 14, 2026 27w ago | 8-K | $3.15 $5.10 | ▲ +61.90% | ▲ +55.86% | $2.96 (−6.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers